Stoke Therapeutics STOK - Options Chain | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc (STOK) Options

Stoke Therapeutics Inc (STOK)

11.21

-0.06

( -0.53% )

Updated: 09:34:39

Delayed by 15 minutes

STOK Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	6.60	10.40	0.00	8.50	0.00	0.00 %	0	0	-
5.00	4.00	8.50	0.00	6.25	0.00	0.00 %	0	0	-
7.50	1.70	5.10	0.00	3.40	0.00	0.00 %	0	0	-
10.00	0.55	4.90	0.00	2.725	0.00	0.00 %	0	0	-
12.50	0.20	1.90	0.45	1.05	0.00	0.00 %	0	18	-
15.00	0.15	0.30	0.15	0.225	0.00	0.00 %	0	90	-
17.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.55	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.65	4.90	1.10	2.775	0.00	0.00 %	0	13	-
15.00	3.00	6.00	3.40	4.50	0.00	0.00 %	0	2	-
17.50	5.30	8.60	0.00	6.95	0.00	0.00 %	0	0	-
20.00	7.80	11.00	0.00	9.40	0.00	0.00 %	0	0	-
22.50	9.70	13.50	0.00	11.60	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SKKSKK Holdings Limited	US$ 2.0353 (85.03%)	68.77M
PDYNPalladyne AI Corporation	US$ 3.2288 (61.44%)	16.42M
QMCOQuantum Corporation	US$ 6.45 (60.45%)	830.09k
REPLReplimune Group Inc	US$ 15.8643 (43.57%)	2.75M
DEVSDevvStream Corporation	US$ 0.67 (33.47%)	54.89M
AMIXAutonomix Medical Inc	US$ 6.30 (-53.40%)	530.43k
APTOAptose Biosciences Inc	US$ 0.1365 (-44.06%)	6.41M
CETXCemtrex Inc	US$ 0.1167 (-40.67%)	11.41M
RMSGReal Messenger Corporation	US$ 3.23 (-22.91%)	143.93k
GEOSGeospace Technologies Corporation	US$ 10.61 (-22.10%)	92.43k
ELABElevai Labs Inc	US$ 0.0193 (-4.46%)	183.66M
VRPXVirpax Pharmaceuticals Inc	US$ 0.7373 (25.03%)	132.3M
SKKSKK Holdings Limited	US$ 2.0397 (85.43%)	81.18M
NVDANVIDIA Corporation	US$ 142.67 (-2.73%)	75.75M
SMCISuper Micro Computer Inc	US$ 33.125 (11.53%)	65.9M

Monksdream

Monksdream 2 months ago

Zardiw

Zardiw 8 months ago

$STOK Chart from #DDAmanda - #1 Stock Screener :

Scans are preset. Push a Button. Find Winners Early:

Z

TimeFades

TimeFades 8 months ago

Choppy day shoulda just stuck with my morning short

TimeFades

TimeFades 8 months ago

Got bullish again and covered

TimeFades

TimeFades 8 months ago

Invest-in-America

Invest-in-America 8 months ago

STOK: "Stoke Therapeutics (NASDAQ:STOK) stock shot up 70% in post-market trading Monday after the company reported positive results from studies for its drug STK-001 in the treatment of children and adolescents with Dravet syndrome, a genetic form of epilepsy. The biotech company said data from two Phase 1/2a studies and two open label extension, or OLE, studies showed “clinically meaningful effects” that included “substantial and durable reductions in convulsive seizure frequency."
https://seekingalpha.com/news/4083468-stoke-stock-soars-post-market-on-epilepsy-drug-data

Dravet Syndrome is an extremely RARE disease in the USA. And the above news does NOT specify nor suggest that STOK's (potential) treatment for Dravet Syndrome will or might have any applications for treatment of EPILEPSY at all. (Be very CAREFUL about news like the above.)

Stoke Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions